Block Copolymer Coatings for Controlled Peptide Clustering

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current medical devices with bioactive polymer coatings face challenges in controlling cellular interactions due to limitations in regulating the clustering of bioactive peptides, which affects cell adhesion and tissue integration.

Innovation Solution

The use of block copolymers with immiscible phase domains allows for the selective attachment of bioactive species, creating self-assembled clusters that enhance cellular adhesion by controlling the shape, size, and spacing of phase domains, mimicking natural surfaces.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If PEG-based comb polymers are used to control peptide clustering, then nano-scale peptide clusters can be created, but the control over clustering is insufficient to optimize cellular adhesion

Engineering Contradiction:

Improvepeptide clustering controlVSAvoidcellular adhesion enhancement

Core Design Contradiction:

Manufacturing precisionVSReliability

Solution Approach 1:

The copolymer is segmented into distinct blocks: a first block containing bioactive peptide sequences and a second block providing structural organization. This segmentation enables the bioactive peptides to self-assemble into controlled clusters within the polymeric coating, achieving both precise clustering control and reliable cellular adhesion enhancement

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The polymeric coating exhibits local quality variations through phase separation, where bioactive peptide clusters are concentrated in specific regions (first phase domains) while other regions (second phase domains) provide structural support. This local concentration of bioactive species optimizes cellular adhesion at critical interfaces while maintaining overall coating integrity

Inventive Principle:

Principle #3Local quality

2Reliability

If bioactive species are attached to polymer blocks, then cellular adhesion is enhanced, but the clustering of bioactive species is not adequately regulated

Engineering Contradiction:

Improvecellular adhesionVSAvoidclustering regulation

Core Design Contradiction:

ReliabilityVSManufacturing precision

Solution Approach 1:

The copolymer undergoes phase separation into distinct immiscible phases, with bioactive species concentrated in first phase domains and structural components in second phase domains. This phase transition during coating formation automatically regulates the clustering of bioactive species, creating controlled nanoscale distributions that enhance cellular adhesion while providing precise clustering regulation

Inventive Principle:

Principle #36Phase transitions

3Adaptability or versatility

If surface structure is modified to regulate cellular interactions, then biological response is influenced, but the control over surface feature size and distribution is limited

Engineering Contradiction:

Improvebiological response controlVSAvoidsurface feature control

Core Design Contradiction:

Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The copolymer coating self-assembles into organized phase domains through spontaneous phase separation, creating surface features with controlled size and distribution without requiring complex external manufacturing processes. This self-service mechanism enables precise control over surface feature morphology while maintaining adaptability to regulate various biological responses

Inventive Principle:

Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach leads to improved cellular adhesion and integration by optimizing the surface structure of medical devices, enhancing their biocompatibility and efficacy in implantable or insertable applications.

Implementation Method 1

The block copolymer contains at least two polymer blocks which phase separate into two or more immiscible phase domains within the polymeric region

Methodology Applied

Scientific EffectPhase separation:

Implementation Method 2

by attaching the bioactive species selectively to at least one polymer block, self-assembled clusters of the bioactive species are created as the blocks phase separate into immiscible phase domains

Methodology Applied

Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS8092818B2Medical devices having bioactive surfaces

Publication Date: 2012.01.10 BOSTON SCIENTIFIC SCIMED INC

AI summary

According to an aspect of the present invention, medical devices are provided, which contain (a) a substrate and (b) a polymeric region disposed over the substrate which contains at least one block copolymer. The block copolymer, in turn, contains at least two polymer blocks which phase separate into two or more immiscible phase domains within the polymeric region. Moreover, a bioactive species is covalently attached to at least one of the polymer blocks. By attaching the bioactive species selectively to at least one polymer block, self-assembled clusters of the bioactive species are created as the blocks phase separate into immiscible phase domains.